Study Details
Study of 2 doses of solifenacin succinate in female subjects with Overactive Bladder.
Clinicaltrials.gov ID
Astellas Study ID
905-EC-007
EudraCT ID
2008-005215-17
Condition
Overactive Bladder Disease
Phase
Phase 4
Age
18 years - N/A
Sex
Female
Product
N/A
Type
Interventional
Trial Dates
Jan 2010 - Jun 2011
Masking
Triple (Participant, Investigator, Outcomes Assessor)
Enrollment number
547
A Study to Evaluate the Overall Effect of Solifenacin 5mg and 10mg on Bladder Wall Thickness and urinary Nerve Growth Factor in Female Subjects with Overactive Bladder and a Diagnosis of Detrusor Overactivity – A double-blind, randomised, placebo-controlled, parallel group, multi-centre study.
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for Study of 2 doses of solifenacin succinate in female subjects with Overactive Bladder.? Contact us by filling our your information to the right and we’ll respond to you.